Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$427M |
| 2 |
Roku
ROKU
|
+$393M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$345M |
| 4 |
AT&T
T
|
+$317M |
| 5 |
Qualcomm
QCOM
|
+$293M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.41B |
| 2 |
Pinduoduo
PDD
|
+$755M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$716M |
| 4 |
AbbVie
ABBV
|
+$558M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.4% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Consumer Staples | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Cracker Barrel
CBRL
$1.29B
| $692K | ﹤0.01% |
4,000
-62,731
| -94% | -$9.55M |
|
|
PTPI
2777
DELISTED
Petros Pharmaceuticals
PTPI
| $692K | ﹤0.01% |
742
+169
| +29% | +$159K |
|
2778
Virco
VIRC
$95M
| $692K | ﹤0.01% |
223,119
+11,910
| +6% | +$37.3K |
|
|
XYF
2779
X Financial
XYF
$201M
| $692K | ﹤0.01% |
186,126
+21,800
| +13% | +$68.1K |
|
|
ALJJ
2780
DELISTED
ALJ Regional Holdings Inc
ALJJ
| $690K | ﹤0.01% |
476,071
+66,351
| +16% | +$92.1K |
|
2781
Oil States International
OIS
$509M
| $688K | ﹤0.01% |
114,100
-158,086
| -58% | -$1.08M |
|
2782
INNOVATE Corp
VATE
$104M
| $688K | ﹤0.01% |
17,450
-8,310
| -32% | -$308K |
|
|
ILPT
2783
Industrial Logistics Properties Trust
ILPT
$565M
| $687K | ﹤0.01% |
29,710
-106,704
| -78% | -$2.39M |
|
2784
Invesco KBW Bank ETF
KBWB
$6.88B
| $687K | ﹤0.01% |
+11,100
| New | +$639K |
|
2785
BioCryst Pharmaceuticals
BCRX
$2.38B
| $686K | ﹤0.01% |
67,470
-1,212,910
| -95% | -$12.5M |
|
|
STAB
2786
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
| $685K | ﹤0.01% |
130,551
-35,100
| -21% | -$192K |
|
|
BDSI
2787
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $685K | ﹤0.01% |
175,300
-140,600
| -45% | -$581K |
|
|
NWLI
2788
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $677K | ﹤0.01% |
2,718
-2,100
| -44% | -$451K |
|
|
ALNA
2789
DELISTED
Allena Pharmaceuticals
ALNA
| $675K | ﹤0.01% |
485,930
+238,919
| +97% | +$398K |
|
2790
Stratus Properties
STRS
$158M
| $671K | ﹤0.01% |
22,000
+1,800
| +9% | +$48.1K |
|
2791
Core Laboratories
CLB
$516M
| $670K | ﹤0.01% |
23,289
-58,113
| -71% | -$1.99M |
|
2792
Ring Energy
REI
$320M
| $669K | ﹤0.01% |
289,800
+48,793
| +20% | +$93K |
|
2793
Covenant Logistics
CVLG
$883M
| $667K | ﹤0.01% |
64,800
+5,200
| +9% | +$46.5K |
|
2794
Galectin Therapeutics
GALT
$207M
| $666K | ﹤0.01% |
307,000
+291,373
| +1,865% | +$653K |
|
|
GHSI
2795
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
| $666K | ﹤0.01% |
+5,550
| New | +$1.12M |
|
2796
Capital Bancorp
CBNK
$615M
| $665K | ﹤0.01% |
34,449
+15,349
| +80% | +$251K |
|
|
AXDX
2797
DELISTED
Accelerate Diagnostics
AXDX
| $662K | ﹤0.01% |
7,960
-10,588
| -57% | -$1.07M |
|
|
JP
2798
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
| $661K | ﹤0.01% |
297,725
+74,900
| +34% | +$183K |
|
2799
Taylor Devices
TAYD
$173M
| $660K | ﹤0.01% |
58,208
+13,170
| +29% | +$144K |
|
|
IRD
2800
Opus Genetics
IRD
$301M
| $660K | ﹤0.01% |
113,620
+39,800
| +54% | +$370K |
|
Similar funds
Renaissance Technologies's Q1 2021 Portfolio in Review
As of Q1 2021, Renaissance Technologies held 3,937 positions worth $80.4B, down 13% from $92.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Renaissance Technologies withdrew a net $16B in Q1 2021, closing 676 positions and reducing 1,579 holdings. Its most notable exit was Micron Technology, an estimated $252M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Renaissance Technologies opened a new position in Paramount Global Class B worth $255M.
- Renaissance Technologies's largest Q1 2021 buy was Paramount Global Class B: 5,644,997 shares worth $255M.
- Renaissance Technologies added most to Tesla in Q1 2021, an estimated $427M increase.
- Renaissance Technologies's biggest Q1 2021 reduction was Baidu, cutting an estimated $1.41B.
- Renaissance Technologies fully exited Micron Technology in Q1 2021, selling an estimated $252M.
- Renaissance Technologies's ten largest holdings make up 10% of its $80.4B portfolio in Q1 2021.
- Renaissance Technologies opened 591 new positions and closed 676 in Q1 2021.
- Renaissance Technologies's portfolio value fell 13% quarter-over-quarter to $80.4B.
Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.